The coefficient of variation of the neural activity, unlike that of velocity, was decreased in animals pre-exposed to 5-HT and <i>mod-1</i> mutants. by Haruka Mori (8082215)

MCM-BP can decrease phosphorylation by DDK but is not a substrate. by Tin Nguyen (231591)

Expression and stability of EspA are decreased in the absence of <i>escA.</i> by Ching-Nan Lin (508587)

<i>Ubr5</i>^<i>mt</i> synovium exhibits markers of increased canonical and decreased non-canonical HH signalling. by David Mellis (2833469)

Letrozole treatment resulted in a decrease in Bacteroidales and increase in Clostridiales. by Scott T. Kelley (158464)

csBAP31-positive cells show decreased survival. by Se-Ri Seo (4597801)

A decrease in cellular RNA increases the insolubility of TDP-43. by Shinnosuke Takagi (428655)

“…(C) Immunoblots of the immunoprecipitated protein with anti-V5 antibody or control IgG. (D) Reverse transcription-PCR (RT-PCR) of hNFL from immunoprecipitated RNA. …”

Learning corresponds with a decrease in intermediate-speed exploratory behaviors. by Caleb Kemere (452950)

Example of K^trans decrease during therapy. by Jean-Philip Daniel Weber (12213395)

ExoY activity causes a decrease in microtubules in PMVECs. by Ron Balczon (453792)

Low glucose induces a decrease in LAMP2 expression. by Delphine Balmer (458897)

Protein 169 increases 80S monosomes and decreases polysomes. by Pavla Strnadova (383776)

The field sensitivity of a pyramidal cell decreases in a high-conductance state. by Florian Aspart (3366014)

Relationship between Differential Hepatic microRNA Expression and Decreased Hepatic Cytochrome P450 3A Activity in Cirrhosis by Raj Vuppalanchi (458660)

“…<div><p>Background and Aim</p><p>Liver cirrhosis is associated with decreased hepatic cytochrome P4503A (CYP3A) activity but the pathogenesis of this phenomenon is not well elucidated. …”

The point mutants E559A, E563A and K567A display altered DNA-binding kinetics. by Bettina Hüntelmann (566945)

“…Whole cell extracts from STAT1-GFP-reconstituted U3A cells were incubated for 15 min with [³³P]-labelled DNA containing a single STAT binding site (M67) and, subsequently, a 750-fold molar excess of unlabelled DNA was added for 0, 5 and 10 min, respectively, before the samples were loaded onto a native polyacrylamide gel. …”

Atorvastatin decreases survival of sensitive but not resistant breast cancer cells. by Colin H. Beckwitt (2037196)

IL-15 treatment results in decreased lipid deposition in 3T3-L1 mature adipocytes and IL-6 and KC production with increasing IL-15 treatment. by Nicole G. Barra (317230)

HSC activation results in a preferential decrease in retinyl esters. by Nicole Testerink (169448)

Decrease in GABA_A immunoreactivity in APP mice. by Ksenia V. Kastanenka (3692380)

Loss of MeOPN results in a decrease in serum resistance. by Lieke B. van Alphen (132099)